TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Dne Pharma AS
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
4,439
|
4,046
|
2,995 |
Financial expenses |
205
|
200
|
1,563 |
Earnings before taxes |
813
|
630
|
-1,335 |
Total assets |
8,691
|
7,587
|
7,316 |
Current assets |
3,901
|
3,402
|
1,910 |
Current liabilities |
2,815
|
2,027
|
2,478 |
Equity capital |
5,022
|
4,615
|
3,927 |
- share capital |
13
|
14
![]() |
14 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
57.8%
|
60.8%
|
53.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
18.3%
|
15.6%
|
-44.6% |
Return on assets (ROA) |
11.7%
|
10.9%
|
3.1% |
Current ratio |
138.6%
|
167.8%
|
77.1% |
Return on equity (ROE) |
16.2%
|
13.7%
|
-34.0% |
Change turnover |
605
|
889
|
316 |
Change turnover % |
16%
|
28%
|
12% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.